An interventional study of Two nare high flow nasal cannula in Oxygen Deficiency, sponsored by Peninsula Health. Status unknown at 1 site in Australia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-05-03.
Sponsored by Peninsula Health · Not applicable, Interventional, and Treatment
High flow nasal cannula (HFNC) are introduced to clinical practice to improve oxygenation. Our group were the first to report the use of HFNC in extubated patients that showed comparable delivery of oxygen and improved comfort. These HFNC are subsequently shown to be useful in several clinical conditions in critically ill patients including respiratory failure due to hypoxia, hypercapnia (exacerbation of chronic obstructive lung disease), or post-extubation, pre-intubation oxygenation, and others.
Recently a new mode of high flow oxygen therapy has been presented on the market where the prongs of high flow have two different diameters. These two-nare size high flow nasal cannula are capable of delivering gases at a flow rate of 15-50 L/min, similar to the conventional HFNP but the difference in the diameters provide different levels of positive pressure as compared to conventional HFNP. This positive pressure could help in gas exchange of patients who need more oxygen. These devices are approved by the Therapeutic Goods Administration (TGA); the medicine and therapeutic regulatory agency of the Australian Government.
Our aim is to compare the two size nare high flow nasal cannula with conventional high flow nasal cannula in extubated patients in intensive care unit in a randomised crossover trial. The comparison will include arterial blood gasses, physiological data including heart rate, respiratory rate, saturations as well as comfort and tolerance of the patients to two size nare high flow nasal cannuale.
This is a randomised crossover study of ventilated patients suitable for extubation was conducted. Potential patients were clinically assessed for suitability of extubation and arterial blood gasses (ABG) were performed prior to extubation to ensure the patients had optimal gas exchange. If found to be suitable for extubation, patients were extubated and were provided with a high flow blend of oxygen and air by a high flow face mask at a rate of 40 litres per minute delivering an FiO2 to ensure an oxygen saturation of 93% + 1 for 30 minutes. At the end of this 30 minute stabilization, ABG were performed and heart rate, blood pressure, and Glasgow coma score (GCS) were recorded. If the patients remained stable they were randomized to either protocol A (Duet HFNP for 30 minutes followed by conventional HFNP for 30 minutes) or protocol B ( conventional HFNP for 30 minutes followed by Duet HFNP for 30 minutes). During both protocols gas flow rate and FiO2 were maintained at exactly the same settings as used during the stabilization period. Blood gases and other physiological observations (heart rate, blood pressure, and respiratory rate, saturations, GCS, comfort score and tolerance score) were recorded at the end of each protocol. The bed side nurse assessed comfort and tolerance of patients to both the devices by a 5-point Likert scale as shown below. For the purpose of this study only medium size cannulas were used to maintain consistency. Subgroup Comparisions will be performed between those with and without nasogastric tubes and between male and female patients. Randomization is performed using sequentially numbered, sealed, opaque envelope to maintain allocation concealment.
Determine patient's comfort:
Patients provided the comfort for both duet HFNP and conventional HFNP prongs using a 5-point Likert scale;
Determine patient's tolerance:
The bedside nurse documented the patient's tolerance using a 5-point Likert scale.
0 Patient never removes the apparatus and does not complain
1,245 studies on the registry are indexed under Hypoxia; 239 are open to participants now.
This study's enrollment of 50 is above the median of 45 across 864 interventional studies indexed under Hypoxia.
Browse Hypoxia studies →Peninsula Health is the lead sponsor of 2 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Recently a new mode of high flow oxygen therapy has presented on the market where the cannula of high flow have different diameters. Left cannula larger in diameter than the right. These two-nare size high flow nasal cannula are capable of delivering gases at a flow rate of 15-60 L/min, similar to the conventional HFNP but the difference in the diameters provide different levels of positive pressure as compared to conventional HFNP. The two nare nasal cannula will be used for 30 minutes to assess the gas exchange, hemodynamic parameters, the tolerance and comfort of the device to the patient.
Device: Two nare high flow nasal cannula
Conventional high flow nasal cannula that has been used for many years will be compared with two-nare high flow nasal cannula. The two nare nasal cannula will be used for 30 minutes to assess the gas exchange, hemodynamic parameters, the tolerance and comfort of the device to the patient.
Device: Two nare high flow nasal cannula
Recently a new mode of high flow oxygen therapy has presented on the market where the prongs of high flow have different diameters .These two-nare size high flow nasal cannula are capable of delivering gases at a flow rate of 15-50 L/min, similar to the conventional HFNP but the difference in the diameters provide different levels of positive pressure as compared to conventional HFNP.
Blood gasses (PaO2 in mmHg)
To compare if there is difference in PaO2 between two nare and connventional high flow nasal cannula.
Time frame: 30 minutes each for a total of one hour.
Blood gasses (PaCO2 in mmHg)
To compare if there is difference in PaCO2 between two nare and connventional high flow nasal cannula.
Time frame: 30 minutes each for a total of one hour.
Blood gasses (SaO2 percentage)
To compare if there is difference in SaO2 between two nare and connventional high flow nasal cannula.
Time frame: 30 minutes each for a total of one hour.
blood pressure (mmHg)
To compare if there is difference in blood pressure between two nare and connventional high flow nasal cannula.
Time frame: 30 minutes each for a total of one hour.
Respiratory rate (breaths per minute)
To compare if there is difference in respiratory rate between two nare and connventional high flow nasal cannula.
Time frame: 30 minutes each for a total of one hour.
Tolerance as assessed by a 5-point Likert scale ranging from 0-4.
To compare if there is difference in tolerance assessed by bedside nurse between two nare and connventional high flow nasal cannula.
Time frame: 30 minutes each for a total of one hour.
Comfort as assessed by a 5-point Likert scale ranging from 1-5.
To compare if there is difference in comfort as reported by the patient between two nare and connventional high flow nasal cannula.
Time frame: 30 minutes each for a total of one hour.
Plan to share: Undecided
This study is status unknown, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Peninsula Health